Opening Update on Inclusion Body Myositis
Update on Inclusion Body Myositis
- Length
- 1 h 9 min
- Level
- Undergraduate
- Recorded
- University of Louisville2026
Chapter 1 of 8: Before the lecture
Traces the clinical presentation, diagnostic criteria, and pathophysiology of inclusion body myositis.
Inclusion body myositis presents as a slowly progressive inflammatory myopathy with asymmetric weakness in the deep finger flexors and quadriceps. Martin Brown reviews diagnostic criteria established by the European Neuromuscular Centre, distinguishing common and uncommon clinical presentations that require confirmatory muscle biopsies. The session evaluates histological hallmarks such as endomysial inflammation, rimmed vacuoles, and mitochondrial abnormalities alongside supportive autoantibody testing. Pathophysiological arguments are weighed between primary myodegeneration driven by misfolded protein accumulation and autoimmune inflammation mediated by cytotoxic T-cells. Finally, therapeutic limitations, ongoing clinical trials, and the role of targeted exercise regimens are examined.
Inclusion body myositis presents as a slowly progressive inflammatory myopathy with asymmetric weakness in the deep finger flexors and quadriceps. Martin Brown reviews diagnostic criteria established by the European Neuromuscular Centre, distinguishing common and uncommon clinical presentations that require confirmatory muscle biopsies. The session evaluates histological hallmarks such as endomysial inflammation, rimmed vacuoles, and mitochondrial abnormalities alongside supportive autoantibody testing. Pathophysiological arguments are weighed between primary myodegeneration driven by misfolded protein accumulation and autoimmune inflammation mediated by cytotoxic T-cells. Finally, therapeutic limitations, ongoing clinical trials, and the role of targeted exercise regimens are examined.
Neurotherapeutics 2018, Aug 22, 15(4) 995-1005
Ann Neurol (2022) 92: 201-212
Neuromuscular Disorders 37 (2024) 36-51
Ann Neurol 2013;73:408-418
J Clin Neuromuscul Dis 2021;23:31-8
Annals of Neurology 2013;73:408-418

This lecture
Talk 11 of 115 of UofL Neurology Grand Rounds.
Choose a node to see how it connects to this lecture. What comes before is on the leftat the top. What comes after is on the rightat the bottom. The ring is what it teaches. People and places are above. Other lectures and books are below.
Press a chosen node again to open it.
Your comment is kept while you sign up.Sign in
Journal of Clinical Neuromuscular Disease 2021;23:31-8
Journal of Clinical Neuroscience 22 (2015) 6-13
Clinical Neurophysiology 127 (2016) 1764-1773
Neurology 2021 May 25;96(21):e2653-e2661
Annals of Neurology 2022 (92) 201-212
Biochimica et Biophysica Acta 1852 (2015) 633-643
Neurology 2004;63:2396-2398
Journal of Neuroimmunology (2012) Volume:249, Issue:1-2
Neurology 2019 Sep 17;93(12):e1193-204
J Neuromuscul Dis 2017;4(4):327-335
Abcuro Announces Topline Results from the MUSCLE Study of Ulviprubart in Patients with Inclusion Body Myositis
MUSCLE Study of Ulviprubart in Patients with Inclusion Body Myositis
Improvement in aerobic capacity after an exercise program in sporadic inclusion body myositis
Sporadic inclusion body myositis: pilot study on the effects of a home exercise program on muscle function, histopathology and inflammatory reaction
Journal of Clinical Neuroscience